2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Alternative Splicing Events in Immune Infiltration of Lung Adenocarcinoma

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          The exact mechanisms of lung adenocarcinoma (LUAD) etiology and pathogenesis remain unclear.

          Material/Methods

          In this study, we evaluated alternative splicing (AS) events in LUAD. We separately analyzed LUAD data from The Cancer Genome Atlas (TCGA) database and AS-related feature lists from SpliceSeq to develop risk models for AS events and further validated risk models for AS events. The association between immune-related features and the risk model of AS events was evaluated.

          Results

          We found that exon skip (ES) and mutually exclusive exons (ME) exhibited the most and least AS events, respectively. The risk score and stage of LUAD patients were strongly associated with prognosis and were independent influences on the prognosis of LUAD. The pathological stage (stage, T, N) and risk model were incorporated to construct a column line graph with better predictive ability. Risk models were associated with tumor microenvironment, and higher risk score values were associated with higher M2 macrophage content and lower M0 macrophage and helper T lymphocyte content. The correlation between core genes and immunity was further assessed by analyzing differentially-expressed genes between risk models. These results suggest an association between the level of risk for AS events and the density of immune cell infiltration.

          Conclusions

          Our findings suggest a clear association between AS risk model and patient prognosis, and was performed to confirm the biological relationship between AS and immunity.

          Related collections

          Most cited references30

          • Record: found
          • Abstract: found
          • Article: not found

          The biology and management of non-small cell lung cancer.

          Important advancements in the treatment of non-small cell lung cancer (NSCLC) have been achieved over the past two decades, increasing our understanding of the disease biology and mechanisms of tumour progression, and advancing early detection and multimodal care. The use of small molecule tyrosine kinase inhibitors and immunotherapy has led to unprecedented survival benefits in selected patients. However, the overall cure and survival rates for NSCLC remain low, particularly in metastatic disease. Therefore, continued research into new drugs and combination therapies is required to expand the clinical benefit to a broader patient population and to improve outcomes in NSCLC.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing

              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Phenotype molding of stromal cells in the lung tumor microenvironment

                Bookmark

                Author and article information

                Journal
                Med Sci Monit
                Med Sci Monit
                Medical Science Monitor
                Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
                International Scientific Literature, Inc.
                1234-1010
                1643-3750
                2021
                05 December 2021
                18 November 2021
                : 27
                : e934491-1-e934491-25
                Affiliations
                [1 ]Department of Clinical Laboratory Medicine, Wenzhou Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University, Wenzhou, Zhejiang, PR China
                [2 ]Department of Respiratory and Critical Care Medicine, Wenzhou Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University, Wenzhou, Zhejiang, PR China
                Author notes
                Corresponding Author: Wei Ye, e-mail: 417119035@ 123456qq.com
                [A]

                Study Design

                [B]

                Data Collection

                [C]

                Statistical Analysis

                [D]

                Data Interpretation

                [E]

                Manuscript Preparation

                [F]

                Literature Search

                [G]

                Funds Collection

                Author information
                https://orcid.org/0000-0002-0057-3306
                Article
                934491
                10.12659/MSM.934491
                8656114
                34864813
                50bc2cd9-50a7-4b87-ba7f-addb954442a9
                © Med Sci Monit, 2021

                This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International ( CC BY-NC-ND 4.0)

                History
                : 21 August 2021
                : 11 November 2021
                Categories
                Database Analysis

                adenocarcinoma of lung,alternative splicing,anesthesia, local,immunotherapy

                Comments

                Comment on this article